Zealand Pharma - Stock Price History | ZEAL

Historical daily share price chart and data for Zealand Pharma since 2021 adjusted for splits. The latest closing stock price for Zealand Pharma as of September 24, 2021 is 34.29.
  • The all-time high Zealand Pharma stock closing price was 44.25 on February 14, 2020.
  • The Zealand Pharma 52-week high stock price is 44.42, which is 29.5% above the current share price.
  • The Zealand Pharma 52-week low stock price is 24.97, which is 27.2% below the current share price.
  • The average Zealand Pharma stock price for the last 52 weeks is 33.25.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Zealand Pharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 36.0653 34.2300 44.2500 23.8600 35.9400 8.25%
2019 21.9843 12.3500 36.4900 12.3500 33.2000 185.96%
2018 14.7305 13.3900 18.4900 11.5100 11.6100 -14.63%
2017 16.8660 17.8200 20.1500 12.4600 13.6000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.449B $0.054B
Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. Zealand Pharma A/S is based in Copenhagen, Denmark.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71